Sort
46,585 grants matching “heart failure”
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy
$1,000,000Steven William Hetts · Filtro Medical Inc. · R42 · FY2023 · CA
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy
$1,000,000Steven William Hetts · Filtro Medical Inc. · R42 · FY2024 · CA
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
$1,000,000Saumya Das · Massachusetts General Hospital · UH3 · FY2016 · TR
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$1,000,000Kyle Mitchell Hocking · Volumetrix, Llc · R44 · FY2025 · HL
GalT-KO Pigs Expressing Primate CD47 to Facilitate Organ Xenografts
$1,000,000Luis Queiroz · Mofa Group, Llc · R42 · FY2014 · AI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
$1,000,000Saumya Das · Massachusetts General Hospital · UH3 · FY2017 · TR
Studying a Human Stem Cell Disease Using iPS Technology
$1,000,000Steven E Artandi · Stanford University · RC1 · FY2010 · HL
SBIR Phase II: A Perfusable, Revascularized, Cardiac-Derived Patch for the Treatment of Heart Disease
$1,000,000Jeffrey J Ross · Miromatrix Medical Inc. · · FY2013 · TIP
An automated platform for direct-from-specimen identification of pathogens common in endocarditis
$1,000,000Alon Singer · Helixbind, Inc. · R44 · FY2019 · AI
GalT-KO Pigs Expressing Primate CD47 to Facilitate Organ Xenografts
$1,000,000Namdori Rachel Mtango · Minitube Of America · R42 · FY2012 · AI
Collaboration Oriented Approach to Controlling High blood pressure (COACH)
$1,000,000David A Dorr · Oregon Health & Science University · R18 · FY2022 · HS
Clinical study of aerosolized KL4 surfactant for neonatal RDS and BPD prevention
$1,000,000Robert Segal · Windtree Therapeutics, Inc. · R44 · FY2016 · HL
Novel Dense Hollow Fiber for Blood Gas Exchange
$1,000,000Jean Montoya · Medarray, Inc. · R44 · FY2010 · HL
Molecular Biomedical Imaging Laboratory
$1,000,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB
Ex Vivo Tolerance for Xenotransplantation of Diabetes P2
$1,000,000Patrick Eugene Kudlacek · Ximerex, Inc. · R44 · FY2012 · DK
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
$1,000,000John L Thompson · Columbia University Health Sciences · U01 · FY2010 · NS
Long-acting PTH for hypoparathyroidism
$1,000,000Laura M Hales · Extend Biosciences, Inc. · R44 · FY2020 · DK
HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- COORDINATING CENTER
$1,000,000Jianwen Cai · Univ Of North Carolina Chapel Hill · N01 · FY2024 · HL
ACHIEVE GreatER: Addressing Cardiometabolic Health Inequities by Early PreVEntion in the Great LakEs Region
$999,999Phillip David Levy · Wayne State University · P50 · FY2023 · MD
Ferritin-Based Molecular Imaging of Cardiac Stem Cell Therapy
$999,999Charles E Murry · University Of Washington · RC1 · FY2010 · HL
The Impact of an Adaptive Patient-Centered Web Application on Medication Optimization in HFrEF Patients
$999,999Michael Dorsch · University Of Michigan At Ann Arbor · R18 · FY2023 · HS
The Impact of an Adaptive Patient-Centered Web Application on Medication Optimization in HFrEF Patients
$999,999Michael Dorsch · University Of Michigan At Ann Arbor · R18 · FY2022 · HS
A novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (hBNP), to treat resistant hypertension
$999,998Brian Laurence Johnson · Antlia Bioscience Inc · R44 · FY2024 · HL
GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS
$999,971University Of Alabama At Birmingham · R01 · FY2003 · HL
Novel Micro-Implant to Measure Intracardiac Pressure in Congenital Heart Patients
$999,969Nader Najafi · Integrated Sensing Systems, Inc. (Issys) · R44 · FY2014 · HL